← Back
$AKRO All transactions

Akero Therapeutics, Inc.

M 10b5-1 Plan

$ Value

$0

Shares

30,000

Price

$0

Filed

Oct 14

Insider

Name

Cheng Andrew

Title

President and CEO

CIK

0001778307

Roles

Director Officer

Transaction Details

Transaction Date

2025-10-10

Code

M

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

380,017

Footnotes

The reported transactions were effected pursuant to a Rule 10b5-1 trading plan dated August 16, 2024, previously adopted by the Reporting Person. | The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $53.92 to $54.09, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. | This option shall vest and become exercisable in 48 equal monthly installments, commencing on December 8, 2023.

Filing Info

Accession No.

0001193125-25-239343

Form Type

4

Issuer CIK

0001744659

Cheng Andrew's History

Date Ticker Type Value
2025-12-09 AKRO D
2025-12-09 AKRO D
2025-12-09 AKRO D
2025-12-09 AKRO D
2025-12-09 AKRO D
2025-12-09 AKRO D
2025-12-09 AKRO D
2025-12-09 AKRO D
2025-12-09 AKRO D
2025-12-09 AKRO D

Other Insiders at AKRO (90d)

No other insider activity at this issuer in the last 90 days.